欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Endocrinology/Hormones > Cilazapril Monohydrate

浏览历史

S81104

Cilazapril Monohydrate

源叶(MedMol) 98%
  • 英文名:
  • Cilazapril Monohydrate
  • 别名:
  • CAS号:
  • 92077-78-6
  • 分子式:
  • C22H31N3O5.H2O
  • 分子量:
  • 435.51
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81104-5mg 98% ¥600.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81104-10mg 98% ¥837.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81104-50mg 98% ¥3348.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Cilazapril Monohydrate is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.
  • 靶点: RAAS
  • 体内研究:
    Cilazapril (1 mg/kg, daily) tends to decrease and the higher dose (10 mg/kg, daily) significantly decreases systolic blood pressure (SBP) in subtotal nephrectomized rats. Cilazapril attenuates the further development of protein uria in a dose-dependent manner in subtotal nephrectomized rats. Cilazapril attenuates the increase in plasma fibrinogen concentration and serum albumin concentration in a dose-dependent manner. Cilazapril reduces serum MCP-1 concentration in the nephrectomized rats. Cilazapril decreases hepatic fibrinogen synthesis through the alleviation of the local inflammatory process and the improvement of hypoalbuminemia. Cilazapril normalizes systolic arterial pressure to 121 mm Hg (SD) in the treated SHR-SP rats. Cilazapril decreases systolic arterial pressure to a nearly normal level and prevents hypertensive retinal vascular changes, probably by improving endothelial function. Cilazapril results in a marked decrease in the Kd of the renal arginine vasopressin (AVP) receptor and an increase in the plasma AVP level in the spontaneously hypertensive rat. Cilazapril exerts a rapid, complete, and persistent antihypertensive effect in the spontaneously hypertensive rats (SHR) in vivo but has no effect on SAP in the normotensive Sprague-Dawley rat. Cilazapril treatment depresses heart performance (28-35%) in SHR but has no effect in the Sprague-Dawley rats. Cilazapril decreases blood pressure to control values and reduces HW:BW in hyperthyroid rats.
  • 参考文献:
    1. Nishida N, et al. Res Commun Chem Pathol Pharmacol, 1994, 84(2), 143-152. 2. Asahi T, et al. Thyroid, 2001, 11(11), 1009-1015. 3. Bhutto IA, et al. Life Sci, 1999, 64(3), PL27-39. 4. Sugimoto K, et al. J Pharmacol Sci, 2004, 94(1), 67-72. 5. Christe ME, et al. Am J Physiol, 1994, 267(5 Pt 2), H2050-2057.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.296 ml 11.481 ml 22.962 ml
    5 mM 0.459 ml 2.296 ml 4.592 ml
    10 mM 0.23 ml 1.148 ml 2.296 ml
    50 mM 0.046 ml 0.23 ml 0.459 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。